Unprecedented success of rituximab therapy for prednisolone- and immunosuppressant-resistant systemic sclerosis-associated interstitial lung disease. (4th May 2017) - Ebata, S; Yoshizaki, A; Fukasawa, T; Nakamura, K; Yamashita, T; Miura, S; Saigusa, R; Ichimura, Y; Takahashi, T; Hirabayashi, M; Taniguchi, T; Akamata, K; et al.